Colorado Blood Cancer Institute /ID# 224250 — Denver, Colorado

Colorado Blood Cancer Institute /ID# 224250 is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Colorado Blood Cancer Institute /ID# 224250 has participated in 1 clinical trials.

Therapeutic areas: Myelofibrosis (MF).

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Colorado Blood Cancer Institute /ID# 224250?

Colorado Blood Cancer Institute /ID# 224250 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Colorado Blood Cancer Institute /ID# 224250 conducted?

Colorado Blood Cancer Institute /ID# 224250 has 1 clinical trials on record. Their work covers Myelofibrosis (MF).

Is Colorado Blood Cancer Institute /ID# 224250 accredited by Crixeo Health?

Colorado Blood Cancer Institute /ID# 224250 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Colorado Blood Cancer Institute /ID# 224250?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.